Daewoong Co Ltd banner
D

Daewoong Co Ltd
KRX:003090

Watchlist Manager
Daewoong Co Ltd
KRX:003090
Watchlist
Price: 26 950 KRW 5.27% Market Closed
Market Cap: ₩1.1T

Net Margin

3.8%
Current
Declining
by 2%
vs 3-y average of 5.8%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
3.8%
=
Net Income
₩77.5B
/
Revenue
₩2.1T

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
3.8%
=
Net Income
₩77.5B
/
Revenue
₩2.1T

Peer Comparison

Country Company Market Cap Net
Margin
KR
Daewoong Co Ltd
KRX:003090
1.1T KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
986.4B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
586.1B USD
Loading...
CH
Roche Holding AG
SIX:ROG
285.6B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
232.8B GBP
Loading...
CH
Novartis AG
SIX:NOVN
239.7B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
301.2B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
157.3B USD
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
123.4B USD
Loading...

Market Distribution

In line with most companies in Korea
Percentile
61th
Based on 2 632 companies
61th percentile
3.8%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

Daewoong Co Ltd
Glance View

Market Cap
1.1T KRW
Industry
Pharmaceuticals

Daewoong Co., Ltd. engages in the management of its subsidiaries. The company is headquartered in Seongnam, Gyeonggi-Do. The firm operates its business mainly through subsidiaries including Daewoong Pharmaceutical Co Ltd, Daewoong Bio Co Ltd, Daewoong Development Co Ltd, and Hanall Biopharma Co Ltd. Daewoong Pharmaceutical Co Ltd, Daewoong Bio Co Ltd and Hanall Biopharma Co Ltd are engaged in the manufacture and sale of pharmaceuticals. Daewoong Development Co Ltd is engaged in real estate rental and supply business. In addition, IDS&Trust Co Ltd manufactures and sells communication-related devices. Daewoong Life Science Co Ltd is engaged in food processing and sales. Pampaeg Co Ltd is engaged in the packaging business of quasi-drugs. Daewoong Management Development Institute Co Ltd is engaged in management and industrial training projects.

Daewoong Co Ltd Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
3.8%
=
Net Income
₩77.5B
/
Revenue
₩2.1T
What is Daewoong Co Ltd's current Net Margin?

The current Net Margin for Daewoong Co Ltd is 3.8%, which is below its 3-year median of 5.8%.

How has Net Margin changed over time?

Over the last 3 years, Daewoong Co Ltd’s Net Margin has decreased from 7.5% to 3.8%. During this period, it reached a low of 3% on Dec 31, 2024 and a high of 8.4% on Dec 31, 2023.

Back to Top